[Influence of histological prostatitis on the clinical features of benign prostatic hyperplasia and prostate cancer]
- PMID: 24873164
[Influence of histological prostatitis on the clinical features of benign prostatic hyperplasia and prostate cancer]
Abstract
Objective: To investigate the influence of histological prostatitis (HP) on the clinical features of benign prostatic hyperplasia (BPH) and prostate cancer (PCa) and its clinical significance.
Methods: We retrospectively studied the data of 273 cases of BPH and 240 cases of PCa, including age, prostate volume, total prostatic special antigen (tPSA), prostatic special antigen density (PSAD), maximum urinary flow rate (MFR) and acute urinary retention (AUR).
Results: Totally, 186 cases of BPH (68.13%) and 45 cases of PCa (18.75%) were complicated by HP, with statistically significant difference between the two groups (P < 0.05). Compared with the patients with BPH only, those complicated by HP showed significantly elevated tPSA, PSAD and total prostate volume (all P < 0.05), decreased MFR (P < 0.05) and increased risk of AUR (P < 0.05). There was no significant difference in the patients' age between the two groups (P > 0.05). The levels of tPSA and PSAD were remarkably higher in the PCa patients complicated by HP than in those with PCa only (all P < 0.05), but no significant differences were found in the other indexes between the two groups (P > 0.05).
Conclusion: HP may play a certain role in the progenesis and progression of HP and PCa, but HP is associated more closely with BPH.
Similar articles
-
Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.BJU Int. 2012 Apr;109(8):1194-7. doi: 10.1111/j.1464-410X.2011.10527.x. Epub 2011 Aug 18. BJU Int. 2012. PMID: 21851551
-
Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.S Afr J Surg. 2012 Nov 12;50(4):127-30. doi: 10.7196/sajs.1095. S Afr J Surg. 2012. PMID: 23217554
-
[Changes of serum total PSA and free PSA in patients with prostate carcinoma and benign prostate hyperplasia].Ai Zheng. 2004 Jun;23(6):701-3. Ai Zheng. 2004. PMID: 15191675 Chinese.
-
The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.Eur Urol. 2011 Jul;60(1):106-17. doi: 10.1016/j.eururo.2011.03.055. Epub 2011 Apr 9. Eur Urol. 2011. PMID: 21497433 Review.
-
The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).BJU Int. 2013 Aug;112(4):432-41. doi: 10.1111/bju.12118. Epub 2013 Apr 12. BJU Int. 2013. PMID: 23650937 Review.
Cited by
-
Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways.World J Surg Oncol. 2018 Jun 14;16(1):108. doi: 10.1186/s12957-018-1400-z. World J Surg Oncol. 2018. PMID: 29898731 Free PMC article.
-
Clinical analysis of transurethral holmium laser enucleation in the treatment of benign prostatic hyperplasia with prostatic inflammation: A prospective research study.Front Surg. 2023 Jan 6;9:1026657. doi: 10.3389/fsurg.2022.1026657. eCollection 2022. Front Surg. 2023. PMID: 36684154 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous